Cited in boardrooms, legal proceedings & government briefings since 2017
Medical cannabis is legal in Austria and adult-use is illegal. Below: a free market overview, with the full sizing, regulation and trade data available from PP.
Medical cannabis sales and registered patients in Austria, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Austria data pack.
Medical sales, EUR
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Medical sales | — | — | €134.3k | |||
| Patients | — | — | 220 |
Forecasts to 2030 — sales, patients and the full Austria series — are in the Austria data pack, or scoped to your question in a bespoke brief.
See the data pack Request a briefSource: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)
From International Cannabis Weekly, our free global briefing.
Hanf Magazin · №466 · 11 Sept 2026 · Regulation
Hanf Magazin · №459 · 17 Jul 2026 · Medical
Newsweed · №448 · 8 May 2026 · Regulation
Newsweed · №428 · 28 Nov 2025 · Regulation
Hanf Magazin · №427 · 21 Nov 2025 · Hemp & CBD
bevinfogroup.com · №416 · 5 Sept 2025 · Business & Investment
The Austrian Narcotics Act (SMG) allows for the production, acquisition, processing, transport, possession, import, or export of narcotic substances for medical or scientific purposes. The SMG refers specifically to medical cannabis, and states that the Austrian Agency for Health and Food Safety (AGES), is the only entity in Austria permitted to cultivate and possess cannabis for the production of medicinal products.
AGES grows several hundred kilograms of cannabis flower each year, which it exports to Germany, where it is processed into dronabinol, some or all of which is re-imported.
Semi-synthetic dronabinol preparations have been available to patients in Austria since 2004 as a magistral treatment in the form of oils or capsules, with 95% pure cannabis-extracted dronabinol available since 2015. Dronabinol prescriptions must be written by a senior physician, with a strict approval process in place.
Dronabinol treatment in Austria is most likely to be used for patients with spasticity, paralysis, multiple sclerosis and other nervous disorders, for the relief of chronic pain that does not respond to any other therapy (cancer, diseases of the nervous system), or loss of appetite, nausea and vomiting in cancer and AIDS.